Researchers develop new materials for chronic wound healing

Researchers are developing new materials and formulations to address the challenges of chronic wound healing, which often affects patients with conditions like diabetes.

A team from Flinders University’s Biomedical Nanoengineering Laboratory has identified vanillin as a potential candidate for wound-healing formulations. Due to its antioxidant, anti-inflammatory, and antibacterial properties, vanillin could provide a cost-effective and safe solution for ulcer treatment and targeted drug delivery. Professor Krasimir Vasilev noted that the compound's abundance and safety history make it a strong candidate for medical applications.

In a separate development, researchers at Empa are working on a smart wound therapy involving a material that releases active ingredients when exposed to visible light. By loading silica nanoparticles with specific agents, the team aims to create a wound patch that allows for controlled drug delivery, potentially reducing the economic burden on healthcare systems and improving treatment effectiveness for chronic conditions such as diabetic foot syndrome.